Mir Hashim is Chief Scientific Officer of Rani Therapeutics Holdings, Inc.. Currently has a direct ownership of 273,265 shares of RANI, which is worth approximately $633,974. The most recent transaction as insider was on Mar 27, 2023, when has been sold 139,000 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 273K
0% 3M change
0% 12M change
Total Value Held $633,974

Mir Hashim Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 27 2023
BUY
Grant, award, or other acquisition
-
139,000 Added 33.72%
273,265 Class A Common Stock
Mar 22 2023
SELL
Payment of exercise price or tax liability
$24,995 $5.95 p/Share
4,201 Reduced 3.03%
134,265 Class A Common Stock
Sep 09 2022
SELL
Payment of exercise price or tax liability
$201,103 $9.89 p/Share
20,334 Reduced 12.8%
138,466 Class A Common Stock
Mar 22 2022
BUY
Grant, award, or other acquisition
-
41,200 Added 20.6%
158,800 Class A Common Stock
Sep 09 2021
BUY
Grant, award, or other acquisition
-
117,600 Added 50.0%
117,600 Class A Common Stock
MH

Mir Hashim

Chief Scientific Officer
San Jose, CA

Track Institutional and Insider Activities on RANI

Follow Rani Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RANI shares.

Notify only if

Insider Trading

Get notified when an Rani Therapeutics Holdings, Inc. insider buys or sells RANI shares.

Notify only if

News

Receive news related to Rani Therapeutics Holdings, Inc.

Track Activities on RANI